These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 34605662

  • 1. Disulfiram Exerts Antiadipogenic, Anti-Inflammatory, and Antifibrotic Therapeutic Effects in an In Vitro Model of Graves' Orbitopathy.
    Wang X, Yang S, Ye H, Chen J, Shi L, Feng L, Wang X, Zhang T, Chen R, Xiao W, Yang H.
    Thyroid; 2022 Mar; 32(3):294-305. PubMed ID: 34605662
    [Abstract] [Full Text] [Related]

  • 2. Disulfiram Exerts Antifibrotic and Anti-Inflammatory Therapeutic Effects on Perimysial Orbital Fibroblasts in Graves' Orbitopathy.
    Wang X, Ye H, Yang S, Sha X, Wang X, Zhang T, Chen R, Xiao W, Yang H.
    Int J Mol Sci; 2022 May 09; 23(9):. PubMed ID: 35563653
    [Abstract] [Full Text] [Related]

  • 3. Dihydroartemisinin Exerts Antifibrotic and Anti-Inflammatory Effects in Graves' Ophthalmopathy by Targeting Orbital Fibroblasts.
    Yang S, Wang X, Xiao W, Xu Z, Ye H, Sha X, Yang H.
    Front Endocrinol (Lausanne); 2022 May 09; 13():891922. PubMed ID: 35663306
    [Abstract] [Full Text] [Related]

  • 4. Biguanides Metformin and Phenformin Generate Therapeutic Effects via AMP-Activated Protein Kinase/Extracellular-Regulated Kinase Pathways in an In Vitro Model of Graves' Orbitopathy.
    Han YE, Hwang S, Kim JH, Byun JW, Yoon JS, Lee EJ.
    Thyroid; 2018 Apr 09; 28(4):528-536. PubMed ID: 29589999
    [Abstract] [Full Text] [Related]

  • 5. Novel Roles of Chloroquine and Hydroxychloroquine in Graves' Orbitopathy Therapy by Targeting Orbital Fibroblasts.
    Guo Y, Li H, Chen X, Yang H, Guan H, He X, Chen Y, Pokharel S, Xiao H, Li Y.
    J Clin Endocrinol Metab; 2020 Jun 01; 105(6):1906-17. PubMed ID: 32249902
    [Abstract] [Full Text] [Related]

  • 6. Potential Therapeutic Activity of Berberine in Thyroid-Associated Ophthalmopathy: Inhibitory Effects on Tissue Remodeling in Orbital Fibroblasts.
    Diao J, Chen X, Mou P, Ma X, Wei R.
    Invest Ophthalmol Vis Sci; 2022 Sep 01; 63(10):6. PubMed ID: 36094643
    [Abstract] [Full Text] [Related]

  • 7. Regulation of Orbital Fibrosis and Adipogenesis by Pathogenic Th17 Cells in Graves Orbitopathy.
    Fang S, Huang Y, Zhong S, Li Y, Zhang Y, Li Y, Sun J, Liu X, Wang Y, Zhang S, Xu T, Sun X, Gu P, Li D, Zhou H, Li B, Fan X.
    J Clin Endocrinol Metab; 2017 Nov 01; 102(11):4273-4283. PubMed ID: 28938397
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. 4-Methylumbelliferone suppresses hyaluronan and adipogenesis in primary cultured orbital fibroblasts from Graves' orbitopathy.
    Yoon Y, Chae MK, Lee EJ, Yoon JS.
    Graefes Arch Clin Exp Ophthalmol; 2020 May 01; 258(5):1095-1102. PubMed ID: 31900640
    [Abstract] [Full Text] [Related]

  • 12. Glycogen Synthase Kinase-3β Mediates Proinflammatory Cytokine Secretion and Adipogenesis in Orbital Fibroblasts from Patients with Graves' Orbitopathy.
    Lee JS, Chae MK, Kikkawa DO, Lee EJ, Yoon JS.
    Invest Ophthalmol Vis Sci; 2020 Jul 01; 61(8):51. PubMed ID: 32735324
    [Abstract] [Full Text] [Related]

  • 13. Inhibitory Effect of Idelalisib, a Selective Phosphatidylinositol 3-Kinase δ Inhibitor, on Adipogenesis in an In Vitro Model of Graves' Orbitopathy.
    Ko J, Kim JY, Lee EJ, Yoon JS.
    Invest Ophthalmol Vis Sci; 2018 Sep 04; 59(11):4477-4485. PubMed ID: 30193323
    [Abstract] [Full Text] [Related]

  • 14. Wnt signalling inhibits adipogenesis in orbital fibroblasts from patients with Graves' orbitopathy.
    Jung SJ, Choi YJ, Park TK, Woo SE, Kim BY, Yoon JS, Jang SY.
    Br J Ophthalmol; 2022 Jul 04; 106(7):1019-1027. PubMed ID: 34193409
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. PRL-1 overexpressed placenta-derived mesenchymal stem cells suppress adipogenesis in Graves' ophthalmopathy through SREBP2/HMGCR pathway.
    Park M, Kim JY, Kang JM, Lee HJ, Banga JP, Kim GJ, Lew H.
    Stem Cell Res Ther; 2021 May 29; 12(1):304. PubMed ID: 34051850
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.